Final answer:
A patient who has received a cardiac stent will typically be on aspirin and clopidogrel as part of dual anti-platelet therapy (DAPT) to prevent clot formation and reduce the risk of cardiovascular events. The duration of DAPT can vary, but it is usually recommended for at least 6 to 12 months. The decision to continue DAPT beyond this time frame should be made in consultation with the treating physician.
Step-by-step explanation:
A patient who has received a cardiac stent is typically prescribed aspirin and clopidogrel as part of dual anti-platelet therapy (DAPT). DAPT is usually given to prevent clot formation and reduce the risk of cardiovascular events, such as heart attacks or strokes. The duration of DAPT can vary depending on individual patient factors, the type of stent used, and the specific clinical situation. In general, patients may be on aspirin and clopidogrel for at least 6 to 12 months after receiving a cardiac stent. However, the decision to continue DAPT beyond this time frame is based on a careful assessment of the individual's risks and benefits, and should be made in consultation with the treating physician.